Detection of Anti-SARS-CoV-2-S1 RBD-Specific Antibodies Prior to and during the Pandemic in 2011–2021 and COVID-19 Observational Study in 2019–2021

Detection of Anti-SARS-CoV-2-S1 RBD-Specific Antibodies Prior to and during the Pandemic in 2011–2021 and COVID-19 Observational Study in 2019–2021

Background: Longitudinal surveys to monitor the seroprevalence are required to support efforts for assessment of the levels of endemic stability in certain countries. We investigated seroprevalence of anti-SARS-CoV-2-S1 receptor-binding domain (RBD)-specific antibodies in the serum samples in 2011–2...

Full description

Bibliographic Details
Main Authors: Nadezhda G. Gumanova, Alexander U. Gorshkov, Natalya L. Bogdanova, Andrew I. Korolev, Oxana M. Drapkina
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Vaccines
Subjects:
COVID-19
Sputink V
vaccination
seroprevalence
collective immunity
Online Access:https://www.mdpi.com/2076-393X/10/4/581

Internet

https://www.mdpi.com/2076-393X/10/4/581

Similar Items